Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Classifica tra le azioni #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Prezzo delle azioni
$0.00023723
Ultima sincronizzazione: 2024-08-26
Capitalizzazione di mercato
$1.41K
Variazione (1 giorno)
111.67%
Variazione (1 anno)
0.00%
Paese
FR
Scambia Pharnext S.A. (ALPHA)

Categoria

Storico dividendi per Pharnext S.A. (ALPHA)
Pharnext S.A. (simbolo azionario: ALPHA) ha effettuato un totale di 1 pagamenti di dividendi.
La somma totale dei dividendi (rettificata per split azionari) è: $0.20
Rendimento da dividendo (TTM): 0
Pagamenti dei dividendi per Pharnext S.A. (ALPHA) dal 2024 al 2026
Pagamenti annuali dei dividendi
Anno Dividendo (rettificato per split azionari) Cambia
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Elenco di tutti i pagamenti di dividendi
Anno Dividendo Cambia
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Dividendi di aziende simili o concorrenti
Azienda Numero di pagamenti di dividendi Il paese
0.00%
US
0.00%
NL
0.00%
CH
29.00%
BE
0.00%
KR